SYNH | tickerfilter.com

Fundamental analysis

17%

Profitability 13%

Dept financing 40%

Liquidity 14%

Performance 16%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

0 0%

1 Month

0 0%

3 Months

0 0%

6 Months

0 0%

1 Year

0 0%

2 Year

20.16%

Key data

Stock price

$42.98

P/E Ratio

29.73

DAY RANGE

N/A - N/A

EPS

$1.44

52 WEEK RANGE

N/A - N/A

52 WEEK CHANGE

N/A

MARKET CAP

4.405 B

YIELD

N/A

SHARES OUTSTANDING

103.714 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

1.11

PUBLIC FLOAT

AVERAGE 10 VOLUME

N/A

AVERAGE 30 VOLUME

N/A

Company detail

CEO: Michael Bell
Region: US
Website:
Employees: 23,000
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

inc research/inventiv health has become syneos health, the only fully integrated end-to-end clinical and commercial solution organization. we are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. our new business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.

SYNH - Syneos Health Inc